Physician profile
Won Kim
NPI 1508022997
$18,524.80
in general payments reported to CMS, 2019-2025
12 companies · $650 in 2025
The $650 reported for 2025 was more than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $268 · 2021: $820 · 2022: $12K · 2023: $4,007 · 2024: $578 · 2025: $650.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $3,213 · Food and Beverage: $1,903 · Travel and Lodging: $101 · Education: $18.09.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $3,212.50 |
| Food and Beverage | $1,903.41 |
| Travel and Lodging | $100.60 |
| Education | $18.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Monteris Medical Corporation | $14,616.50 | 2019-2025 | Neuroblate |
| Stryker Corporation | $1,264.05 | 2019-2025 | Core, Nico Brainpath, Nico Myriad |
| Integra Lifesciences Corporation | $731.01 | 2021-2025 | Duraseal Exact Spinal Sealant System, Codman Certas, Cusa Clarity |
| Brainlab, INC. | $722.00 | 2023 | Image Guided Surgical Device |
| Servier Pharmaceuticals LLC | $309.71 | 2021 | |
| Medtronic, INC. | $241.24 | 2021-2022 | |
| Viz.Ai, INC. | $190.45 | 2021 | |
| Clearpoint Neuro, INC. | $150.00 | 2024 | Clearpoint |
| Boston Scientific Corporation | $138.27 | 2022 | |
| Medtronic USA, INC. | $115.68 | 2019 | |
| Zap Surgical Systems, INC. | $27.80 | 2022 | |
| Merck Sharp & Dohme LLC | $18.09 | 2024 | Welireg |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Won Kim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.